Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Assets
Unrestricted cash and cash equivalents		$ 409,660	$ 178,102
Restricted cash and cash equivalents		96,968	80,859
Loans, interest and fees receivable:
Loans, interest and fees receivable, at fair value		1,026,424	417,098
Loans, interest and fees receivable, gross		470,293	667,556
Allowances for uncollectible loans, interest and fees receivable (including $55.1 million and $120.9 million associated with variable interest entities at December 31, 2021 and December 31, 2020, respectively)		(57,201)	(124,961)
Deferred revenue (including $8.2 million and $10.3 million associated with variable interest entities at December 31, 2021 and December 31, 2020, respectively)		(29,281)	(39,456)
Net loans, interest and fees receivable		1,410,235	920,237
Property at cost, net of depreciation		7,335	2,240
Investments in equity-method investee		0	1,415
Operating lease right-of-use assets		4,016	9,181
Prepaid expenses and other assets		15,649	15,180
Total assets		1,943,863	1,207,214
Liabilities
Accounts payable and accrued expenses		42,287	41,731
Operating lease liabilities		4,842	13,776
Notes Payable, net held by VIEs		1,278,864	882,610
Notes payable associated with structured financings, at fair value (associated with variable interest entities)		0	2,919
Convertible senior notes		0	24,386
Senior notes, net		142,951	0
Income tax liability		47,770	25,932
Total liabilities		1,516,714	991,354
Commitments and contingencies (Note 12)
Shareholders' Equity
Common stock, no par value, 150,000,000 shares authorized: 14,804,408 and 16,115,353 shares issued at December 31, 2021 and December 31, 2020, respectively; 14,804,408 and 16,115,353 (including 1,459,233 loaned shares to be returned at December 31, 2020) shares outstanding at December 31, 2021 and December 31, 2020, respectively		0	0
Paid-in capital		227,763	194,950
Retained earnings (deficit )		60,236	(117,666)
Total shareholders’ equity		287,999	77,284
Noncontrolling interests		(500)	(774)
Total equity		287,499	76,510
Total liabilities, preferred stock and equity		1,943,863	1,207,214
Series A Preferred Stock [Member]
Liabilities
Preferred stock	[1]	40,000	40,000
Preferred stock	[1]	40,000	40,000
Series B Preferred Stock [Member]
Liabilities
Preferred stock		99,650	99,350
Preferred stock		99,650	99,350
Shareholders' Equity
Series B preferred stock, no par value, 3,188,533 shares issued and outstanding at December 31, 2021 and 0 shares issued and outstanding at December 31, 2020 (liquidation preference - $79.7 million) (1)	[1]	$ 0	$ 0

[1] Both the Series A preferred stock and the Series B preferred stock have no par value and are part of the same aggregate 10,000,000 shares authorized.